Skip to main content
Clinical Trials/NCT04986215
NCT04986215
Unknown
Not Applicable

Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy

Changhai Hospital1 site in 1 country300 target enrollmentOctober 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Space Occupying
Sponsor
Changhai Hospital
Enrollment
300
Locations
1
Primary Endpoint
Differential lncRNA detected by sequencing
Last Updated
4 years ago

Overview

Brief Summary

To clarify the value of genomic testing in the clinical diagnosis or prognosis of pancreatic space occupation, provide a basis for the selection of clinical diagnosis methods for pancreatic space occupation, optimize clinical management strategies, and improve the prognosis of patients.

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
September 1, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Xiangyu Kong

Associate Professor

Changhai Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18-85, no gender limit
  • Imaging examinations suggest that the clear pancreas has clear space-occupying lesions
  • Admitted to our department, ready to undergo endoscopic ultrasound biopsy to confirm the diagnosis

Exclusion Criteria

  • There are contraindications for endoscopic ultrasound biopsy
  • Failed to join the group or refused follow-up due to various reasons

Outcomes

Primary Outcomes

Differential lncRNA detected by sequencing

Time Frame: June 2023

The diagnosis of lncRNA in pancreatic space occupying

Differential mRNA detected by sequencing

Time Frame: June 2023

The diagnosis of mRNA in pancreatic space occupying

Differential microRNA detected by sequencing

Time Frame: June 2023

The diagnosis of microRNA in pancreatic space occupying

Study Sites (1)

Loading locations...

Similar Trials